Health & Medicine
Cutting-edge developments in biomedical research, public health, and clinical practice at Harvard’s medical institutions.
Nicole Maestas
The Harvard health economist not afraid to get in the weeds
by Max J. Krupnick
Presiding during the Pandemic
President Bacow on pandemic and academic Harvard
by John S. Rosenberg
The Omicron Semester
Staving off the surge
by John S. Rosenberg
Does Omicron Cause “Mild” COVID-19?
New evidence suggests the threat of severe infections.
by Jonathan Shaw
Omnibus Omicron Intelligence
Harvard Medical School experts on viral evolution, vaccines, the immune system—and what’s next
by Jonathan Shaw
The Omicron Semester
Harvard prepares for a pandemic-influenced spring term.
by John S. Rosenberg
President Bacow on Harvard in the Months Ahead
Perspectives on the pandemic, continued academic progress, finances, governance, and more
by John S. Rosenberg
Harvard Goes Remote for January Term as Pandemic Intensifies
Rising coronavirus cases prompt a new round of precautions
by John S. Rosenberg
A Surge on Top of a Surge
Rising cases on campus—and in communities worldwide
by Jonathan Shaw
Against Delta, Moderna Edges Pfizer, but Omicron Looms
A head-to-head comparison in 440,000 vaccinated veterans finds Moderna’s vaccine is slightly more effective than Pfizer’s at preventing a range of COVID-19 outcomes.
by Jonathan Shaw
“No Longer Eligible to Work at Harvard”
The University’s COVID-19 vaccine mandate takes effect December 8.
by John S. Rosenberg